Efficacy and safety of acetylcysteine for the prevention of liver injury in COVID-19 intensive care unit patients under treatment with remdesivir

AIM: The present double-blinded placebo-controlled randomized clinical trial evaluated prophylactic use of acetylcysteine for the prevention of liver injury in patients with severe COVID-19 pneumonia under treatment with remdesivir. BACKGROUND: Liver injury is reportedly common in patients with seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Mousapour, Pouria, Hamidi Farahani, Ramin, Mosaed, Reza, Asgari, Ali, Hazrati, Ebrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589135/
https://www.ncbi.nlm.nih.gov/pubmed/36311968
http://dx.doi.org/10.22037/ghfbb.v15i3.2565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589135/
https://www.ncbi.nlm.nih.gov/pubmed/36311968
http://dx.doi.org/10.22037/ghfbb.v15i3.2565

Ejemplares similares